Rabeprazole in a one-week eradication therapy of Helicobacter pylori: Comparison of different dosages

Francesco Di Mario, Nadia Dal Bò, Giovanni Aragona, Ali M. Moussa, Veronica Iori, Giulia M. Cavestro, Alberto Pilotto, Gioacchino Leandro, Marilisa Franceschi, Massimo Rugge, Angelo Franzè

Research output: Contribution to journalArticle

Abstract

Aim: Many data regarding omeprazole-, lanzoprazole- and pantoprazole-based triple therapy for Helicobacter pylori (H. pylori) eradication have been reported, but there is few data present regarding rabeprazole (R). We report the efficacy and tolerability of rabeprazole in different dosages in association with clarithromycin (C) and tinidazole (T) in H. pylori eradication. Design and Methods: Ninety-four H. pylori-positive patients with dyspeptic symptoms were enrolled and randomly allocated to eradication therapy in two different one-week regimens. In regimen A, 47 patients received R 20 mg b.i.d, C 500 mg b.i.d and T 500 mg b.i.d, while in regimen B, 47 patients received R 10 mg b.i.d, C 500 mg b.i.d and T 500 mg b.i.d. Eradication of H. pylori was evaluated by a 13C urea breath test (UBT) two months after the end of the therapy. Results: Four patients (two in each regimen) did not complete treatment. The H. pylori eradication rate was 91.4% in group A compared to 89.3% in group B (P-value not significant). Minor side-effects were reported in 4.2% of group A and 6.4% of group B patients. Conclusion: Rabeprazole showed good efficacy and tolerability in one-week H. pylori therapy at 20 mg b.i.d and 10 mg b.i.d, suggesting the use of the lower dosage.

Original languageEnglish
Pages (from-to)783-786
Number of pages4
JournalJournal of Gastroenterology and Hepatology
Volume18
Issue number7
DOIs
Publication statusPublished - Jul 1 2003

Keywords

  • Different dosage
  • Eradication therapy
  • Helicobacter pylori
  • Rabeprazole

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Fingerprint Dive into the research topics of 'Rabeprazole in a one-week eradication therapy of Helicobacter pylori: Comparison of different dosages'. Together they form a unique fingerprint.

  • Cite this